Pharmacologic and clinical profile of dexamethasone intravitreal implant

Author： Robinson Michael R   Whitcup Scott M  

Publisher： Informa Healthcare

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.5, Iss.6, 2012-11, pp. : 629-647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NICE recommends dexamethasone intravitreal implant, . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 631, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Dexamethasone intravitreal implant cost effective in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Dexamethasone intravitreal implant a sight for sore eyes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

By Ciulla Thomas A   Harris Alon   McIntyre Nathaniel   Jonescu-Cuypers Christian  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 953-959

Informa Healthcare

Access to resources Recommend Favorite

Dexamethasone: Diffuse corneal oedema following migration of intravitreal implant in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1437, 2013-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite